about
Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meetingMind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures.A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysisAssociation between the awareness of osteoporosis and the quality of care for bone health among Korean women with osteoporosis.The risk of osteoporotic fractures and its associating risk factors according to the FRAX model in the Iranian patients: a follow-up cohort.The Epidemiology of Hip and Major Osteoporotic Fractures in a Dutch Population of Community-Dwelling Elderly: Implications for the Dutch FRAX® Algorithm.Burden of First Osteoporotic Hip Fracture in Spain: A Prospective, 12-Month, Observational Study.Management of osteoporosis of the oldest old.Goal-directed treatment of osteoporosis in Europe.Nutrition and bone health in women after the menopause.Systematic review of the association between climate and hip fractures.Reprint of: The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide.The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide.The position of strontium ranelate in today's management of osteoporosis.Swedish osteoporosis care.FRAX and fracture prediction without bone mineral density.SIGN Guidelines for Scotland: BMD Versus FRAX Versus QFracture.Burden of high fracture probability worldwide: secular increases 2010-2040.Pharmacological treatment of osteoporosis in the oldest old.Telementoring: a novel approach to reducing the osteoporosis treatment gap.Overview of Fracture Prediction Tools.Incidence of hip fracture in Brazil and the development of a FRAX model.Bisphosphonate-functionalized hyaluronic acid showing selective affinity for osteoclasts as a potential treatment for osteoporosis.Meeting international standards of secondary fracture prevention: a survey on Fracture Liaison Services in the Netherlands.Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture® Best Practice Framework tool.The interactions between municipal socioeconomic status and age on hip fracture risk.Worldwide uptake of FRAX.The incidence of hip fractures in Estonia, 2005-2012.Critical issues and current challenges in osteoporosis and fracture prevention. An overview of unmet needs.Does osteoporosis influence the marginal peri-implant bone level in female patients? A cross-sectional study in a matched collective.Emerging anabolic agents in the treatment of osteoporosis.FRAX-based intervention and assessment thresholds in seven Latin American countries.[Thoracolumbar spinal fractures in the elderly : Classification and treatment].Adjusting fracture probability by trabecular bone score.Bone mineral density (BMD) and vertebral trabecular bone score (TBS) for the identification of elderly women at high risk for fracture: the SEMOF cohort study.Epidemiology of Hip Fractures in Two Regions of Ukraine.Usefulness of measuring radiographic density of axis vertebra in patients at risk of osteoporosis: A cone-beam computed tomography studyNew and emerging concepts in the use of denosumab for the treatment of osteoporosis
P2860
Q30234621-FCD25CF8-FCE8-4411-8685-E70A9D001DA0Q30236007-66BD0FBC-A87E-4512-93B5-791A71655AC3Q30248756-476166A0-442C-4B5B-80CD-9358A2941F4AQ33610208-B20DA453-53FC-43E2-AD99-118005E5D623Q34325745-18D8F6B9-AD90-4890-BC18-2D98DBD9AA44Q34402171-AD4D9DF4-89D3-45B5-B387-B9A694EE7C83Q35859866-3DD449D1-A2A7-43C2-900C-684DD3D18DA3Q37559240-CFE2676E-5664-4C2D-B397-1F401669282AQ38229503-F254AEA4-FEEC-4510-81EC-7B3C6283E7F9Q38246948-5F018E02-EB60-4CBF-A5B6-8B725426C1D2Q38284363-C231D9EA-443E-4180-A350-ED9D44519505Q38287580-4AC9FA50-665A-42D5-9577-B05B7736BDF7Q38402233-EF17CDBC-5E8D-4625-9CD8-3A0873ADD04EQ38406462-22DAFA32-15EB-4A1A-AF65-EE7A8F1099B6Q38418620-447EA714-E7A7-45A6-AE70-CD3B097B3111Q38563886-DBCA7FC4-E3BE-48EF-9BEC-CBC6F55E1180Q38613173-2FF6D2E7-5232-43E9-BFC1-A696C4BC7EC1Q38664026-DB87CFE8-066E-47DD-9777-1E699B2D2FA4Q39001969-7305A1BC-D980-4309-9AEC-1E422B22BDFEQ39455613-A4262D71-8411-46F1-A4EE-185B2DF182DFQ39579615-CFFE7B44-F82C-47E0-AA4F-64959E205896Q40119539-E81B322A-9A1D-40DC-975E-F38743A4B005Q40612252-F6A4B66A-8769-4454-A0A0-ACA30A00AB16Q40682785-F3783126-4324-4478-9E71-678066660987Q41091960-F928D1F3-1B22-4DD8-818F-987331463163Q41674252-63FD6937-62B6-4DAF-8D6F-8740BFCA529CQ44714014-DCECAE05-A94C-4C90-9FB0-585F1D40F0F8Q45818592-F969E18C-341B-45C0-8D64-F9EEB863105AQ46118052-89FBB9D8-AF8C-43C0-B06B-9A1A6E2AD0DFQ47136618-DAFD3346-C8FE-46E9-AD4A-64B79B4AACC4Q47771081-88D3CA2A-D70F-4D11-9F20-49A221828709Q48012226-5F6607DA-8851-4D38-98DD-085EAA052C07Q49605700-5E227016-1F5B-42B0-A9BA-72BC604091E5Q49978817-278A140F-0D16-46E9-8A99-408A9FA76C4DQ50944575-DCB9F4E3-8FAC-4485-A492-8F5E3B9A8E92Q52992562-0795D706-3D32-4098-8F09-871B099684A8Q55437116-B437E8AD-D64C-4E14-A34D-0E9FAF85DA1DQ58124549-5BD0C6F1-B8FA-45DE-ADF9-863AFC674023Q58583955-E9E34390-D859-4E6D-A11B-90E2F066527A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
SCOPE: a scorecard for osteoporosis in Europe.
@en
SCOPE: a scorecard for osteoporosis in Europe.
@nl
type
label
SCOPE: a scorecard for osteoporosis in Europe.
@en
SCOPE: a scorecard for osteoporosis in Europe.
@nl
prefLabel
SCOPE: a scorecard for osteoporosis in Europe.
@en
SCOPE: a scorecard for osteoporosis in Europe.
@nl
P2093
P1476
SCOPE: a scorecard for osteoporosis in Europe.
@en
P2093
E V McCloskey
F Borgström
J Compston
J Stenmark
P2888
P356
10.1007/S11657-013-0144-1
P407
P577
2013-09-13T00:00:00Z